Comorbidities

1-16 of 187

• 

  RestartResume

  Analytics in Ophthalmology

  RestartResume

  Analytics in Ophthalmology

  July 2026 Issue

  Analytics in Ophthalmology

  Tracy J. Kenniff, MBA, OCS; Jay Greiling

  Tracy J. Kenniff, MBA, OCS; Jay Greiling

• 

  RestartResume

  Visualizing the Angle

  RestartResume

  Visualizing the Angle

  July 2026 Issue

  Visualizing the Angle

  Prasanna Venkatesh Ramesh, MBBS, MS, MNAMS, FICO, FAICO (Cataract, Glaucoma)

  Prasanna Venkatesh Ramesh, MBBS, MS, MNAMS, FICO, FAICO (Cataract, Glaucoma)

• 

  RestartResume

  MIGS Device Selection in Practice

  RestartResume

  MIGS Device Selection in Practice

  July 2026 Issue

  MIGS Device Selection in Practice

  Nathan Kerr, Mbchb, MD

  Nathan Kerr, Mbchb, MD

• 

  RestartResume

  The Limits of Combining Phacoemulsification and MIGS

  RestartResume

  The Limits of Combining Phacoemulsification and MIGS

  July 2026 Issue

  The Limits of Combining Phacoemulsification and MIGS

  Keith Barton, MD, FRCP, FRCS; Vishal Shah, MA, FRCOphth

  Keith Barton, MD, FRCP, FRCS; Vishal Shah, MA, FRCOphth

• 

  RestartResume

  MIGS and Cataract Surgery

  RestartResume

  MIGS and Cataract Surgery

  July 2026 Issue

  MIGS and Cataract Surgery

  Cathleen M. Mccabe, MD

  Cathleen M. Mccabe, MD

• 

  RestartResume

  Integrating MIGS Without Disrupting Efficiency

  RestartResume

  Integrating MIGS Without Disrupting Efficiency

  July 2026 Issue

  Integrating MIGS Without Disrupting Efficiency

  Deborah Ristvedt, DO

  Deborah Ristvedt, DO

• 

  RestartResume

  Canal-Based MIGS

  RestartResume

  Canal-Based MIGS

  July 2026 Issue

  Canal-Based MIGS

  Murat Gunay, MD; Ronald L. Fellman, MD

  Murat Gunay, MD; Ronald L. Fellman, MD

• 

  RestartResume

  The Glaucoma Pipeline

  RestartResume

  The Glaucoma Pipeline

  Comorbidities

  The Glaucoma Pipeline

  Arsham Sheybani, MD

  Arsham Sheybani, MD

• 

  RestartResume

  An Anterior Segment Surgeon’s Take on Intravitreal Injection

  RestartResume

  An Anterior Segment Surgeon’s Take on Intravitreal Injection

  Comorbidities

  An Anterior Segment Surgeon’s Take on Intravitreal Injection

  D. Brian Kim, MD

  D. Brian Kim, MD

• 

  RestartResume

  The Future of the MIGS Sector

  RestartResume

  The Future of the MIGS Sector

  Comorbidities

  The Future of the MIGS Sector

  Blake K. Williamson, MD, MPH, MS | Williamson Eye Center, Louisiana

  Blake K. Williamson, MD, MPH, MS | Williamson Eye Center, Louisiana

• 

  RestartResume

  Endothelial Cell Loss and MIGS: What We Know and Don't Know

  RestartResume

  Endothelial Cell Loss and MIGS: What We Know and Don't Know

  Comorbidities

  Endothelial Cell Loss and MIGS: What We Know and Don't Know

  Iqbal Ike K. AHMED, MD; Georges M. Durr, MD, FRCSC

  Iqbal Ike K. AHMED, MD; Georges M. Durr, MD, FRCSC

• 

  RestartResume

  MIGS and the Comprehensive Ophthalmologist

  RestartResume

  MIGS and the Comprehensive Ophthalmologist

  Comorbidities

  MIGS and the Comprehensive Ophthalmologist

  Michael Patterson, DO

  Michael Patterson, DO

• 

  RestartResume

  How We Incorporated MIGS Into a Busy Cataract and Refractive Surgery Practice

  RestartResume

  How We Incorporated MIGS Into a Busy Cataract and Refractive Surgery Practice

  Comorbidities

  How We Incorporated MIGS Into a Busy Cataract and Refractive Surgery Practice

  Blake A. Booth, MD; Matthew D. Smith, MD

  Blake A. Booth, MD; Matthew D. Smith, MD

• 

  RestartResume

  Glaucoma Research Highlights

  RestartResume

  Glaucoma Research Highlights

  Comorbidities

  Glaucoma Research Highlights

  Geoffrey T. Emerick, MD

  Geoffrey T. Emerick, MD

• 

  RestartResume

  MIGS Stent Devices: What's the Evidence?

  RestartResume

  MIGS Stent Devices: What's the Evidence?

  Comorbidities

  MIGS Stent Devices: What's the Evidence?

  Philip S. Garza, MD, MS; Manjool Shah, MD

  Philip S. Garza, MD, MS; Manjool Shah, MD

• 

  RestartResume

  Newly Approved Glaucoma Therapy Increases Options for Patients and Providers

  RestartResume

  Newly Approved Glaucoma Therapy Increases Options for Patients and Providers

  Comorbidities

  Newly Approved Glaucoma Therapy Increases Options for Patients and Providers